Advances in the medical and surgical treatment of Takayasu arteritis

Current Opinion in Rheumatology

Volumn 17, Issue 1, 2005, Pages 16-24

  Liang, Patrick ^a   Hoffman, Gary S ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Anti tumor necrosis factor ; Bypass grafting; Percutaneous transluminal angioplasty; Revascularization procedures; Stents; Takayasu arteritis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETANERCEPT; EVEROLIMUS; GAMMA INTERFERON; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLATELET DERIVED GROWTH FACTOR; PREDNISOLONE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AORTA ARCH SYNDROME; ARTERY INTIMA PROLIFERATION; BYPASS SURGERY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; ENDARTERECTOMY; ENDOVASCULAR SURGERY; HUMAN; ISCHEMIA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RELAPSE; REMISSION; RESTENOSIS; REVASCULARIZATION; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; HUMANS; RHEUMATOLOGY; TAKAYASU'S ARTERITIS;

EID: 11344283576     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000146607.65808.37     Document Type: Review

References (56)

1. Kerr GS, Hallahan CW, Giordano J, et al.: Takayasu arteritis. Ann Intern Med 1994, 120:919-929.
2. Numano F: Takayasu's arteritis: clinical aspects. In Inflammatory Diseases of Blood Vessels. Edited by Hoffman GS, Weyand CM. New York: Marcel Dekker; 2002:455-466
3. Liang GC, Madayag M: Multiple percutaneous transluminal angioplasties and low dose methotrexate for Takayasu's arteritis. J Rheumatol 1989, 16:1370-1373.
4. Besson-Léaud L, Grenier N, Besson-Léaud M, et al.: Maladie de Takayasu: intėrêt du traitement par methotrexate. Arch Pediatr 2001, 8:724-727.
5. Hoffman GS, Leavitt RY, Kerr GS, et al.: Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994, 37:578-582.
6. Valsakumar AK, Valappil UC, Jorapur V, et al.: Role of immunosuppressive therapy on clinical immunological, and angiographic outcome in active Takayasu's arteritis. J Rheumatol 2003, 30:1793-1798.
7. Horigome H, Kamoda T, Matsui A: Treatment of glucocorticoid-dependent Takayasu's arteritis with cyclosporine. Med J Aust 1999, 170:566.
8. Daina E, Schieppati A, Remuzzi G: Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med 1999, 130:422-426.
9. Haberhauer G, Kittl EM, Dunky A, et al.: Beneficial effects of leflunomide in glucocorticoid- and methotrexate-resistant Takayasu's arteritis. Clin Exp Rheumatol 2001, 19:477-478.
10. Hoffman GS, Merkel PA, Brasington RD, et al.: Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004, 50:2296-2304.
11. Shelhamer JH, Volkman DJ, Parillo JE, et al.: Takayasu's arteritis and its therapy. Ann Intern Med 1985, 103:121-126.
12. Inder SJ, Bobryshev YV, Cherian SM, et al.: Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease. Angiology 2000, 51:565-579.
13. Seko Y: Takayasu's arteritis: pathogenesis. In: Inflammatory Diseases of Blood Vessels. Edited by Hoffman GS, Weyand CM. New York: Marcel Dekker; 2002:443-453
14. Seko Y, Sugishita K, Sato O, et al.: Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis. J Vasc Res 2004, 41:84-90.
15. Weyand CM, Goronzy JJ: Medium and large vessel vasculitis. N Engl J Med 2003; 349:160-169. A comprehensive review of the current understanding of pathogenesis of large vessel vasculitides.
16. Weyand CM, Kaiser M, Yang H, et al.: Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 2002, 46:457-466.
17. Nesher G, Berkun Y, Mates M, et al.: Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004, 50:1332-1337.
18. Weaver FA, Yellin AE, Campen DH, et al.: Surgical procedures in the management of Takayasu's arteritis. J Vasc Surg 1990, 12:429-439.
19. Lagneau P, Michel JB, Vuong PN: Surgical treatment of Takayasu's disease. Ann Surg 1987, 205:157-166.
20. Liang P, Tan-Ong M, Hoffman GS: Takayasu's arteritis: vascular interventions and outcomes. J Rheumatol 2004, 31:102-106.
21. Weaver FA, Kumar SR, Yellin AE, et al.: Renal revascularization in Takayasu arteritis-induced renal artery stenosis. J Vasc Surg 2004, 39:749-757. This article provides good long-term follow-up of patients, a feature that is often lacking in other publications on the subject. Another strength is the description of outcomes for one type of surgical intervention in one anatomic location.
22. Miyata T, Sato O, Koyama H, et al.: Long-term survival after surgical treatment of patients with Takayasu's arteritis. Circulation 2003, 108:1474-1480.
23. Ishikawa K: Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation 1978, 57:27-35.
24. Ishikawa K, Shunzo M: Peripheral arterial and aortic diseases: long-term outcome for 120 Japanese patients with Takayasu's disease: clinical and statistical analyses of related prognostic factors. Circulation 1994, 90:1855-1860.
25. Miyata T, Sato O, Deguchi J, et al.: Anastomotic aneurysms after surgical treatment of Takayasu's arteritis: a 40-year experience. J Vasc Surg 1998, 27:438-445.
26. Erdogan A, Gilgil E, Öz N, et al.: PTFE patching to prevent anastomotic aneurysm formation in Takayasu's arteritis. Eur J Vasc Endovasc Surg 2003, 25:478-480.
27. Shiiya N, Matsuzaki K, Watanabe T, et al.: Descending aorta to carotid bypass for Takayasu arteritis as a redo operation. Ann Thorac Surg 2003, 76:283-285.
28. Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, et al.: Takayasu's arteritis: clinical study of 107 cases. Am Heart J 1977, 93:94-103.
29. Nagata S: Present state of autopsy cases of Takayasu's arteritis (aortitis syndrome) in Japan. J Jpn Coll Angiol 1990, 30:1303-1308.
30. Amano J, Suzuki A: Coronary artery involvement in Takayasu's arteritis: collective review and guideline for surgical treatment. J Thorac Cardiovasc Surg 1991, 102:554-560.
31. Endo M, Tomizawa Y, Nishida H, et al.: Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg 2003, 125:570-577.
32. Kim KH, Lee C, Ahn H: Successful treatment in a patient with Takayasu's arteritis and Marfan syndrome. Ann Thorac Surg 2002, 74:908-910.
33. Kim DI, Huh SH, Lee BB: Aortic endarterectomy in Takayasu's arteritis and Leriche's syndrome. J Cardiovasc Surg (Torino) 2002, 43:751-753.
34. Pajari R, Hekali P, Harjola PT: Treatment of Takayasu's arteritis: an analysis of 29 patients. Thorac Cardiovasc Surg 1986, 34:176-181.
35. Fava MP, Foradori GB, Garcia CB, et al.: Percutaneous transluminal angioplasty in patients with Takayasu arteritis: five-year experience. J Vasc Interv Radiol 1993, 4:649-652.
36. Tyagi S, Singh B, Kaul UA, et al.: Balloon angioplasty for renovascular hypertension in Takayasu's arteritis. Am Heart J 1993, 125:1386-1393.
37. Kissin EY, Merkel PA: Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 2003, 16:31-37. The authors provide a good summary of new imaging modalities for diagnosis and follow-up of TA patients, emphasizing the strengths and weaknesses of each.
38. Hoffman GS, Ahmed AE: Surrogate markers of disease activity in patients with Takayasu's arteritis: a preliminary report from the International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 1998, 66(suppl 1):S191-S194.
39. Salvarani C, Cantini F, Boiardi L, et al.: Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol 2003, 21(suppl 32):S23-S28.
40. Matsuyama A, Sakai N, Ishigami M, et al.: Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 2003, 108:1469-1473.
41. Numano F: Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 2000, 75:S1-S8.
42. Filer A, Nicholls D, Corston R, et al.: Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage. J Rheumatol 2001, 28:2752-2753.
43. Avery RK: Cardiac-allograft vasculopathy. N Engl J Med 2003, 349:829-830.
44. Mancini D, Pinney S, Burkhoff D, et al.: Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003, 108:48-53.
45. Eisen HJ, Tuzcu EM, Dorent R, et al.: Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003, 349:847-858.
46. Holmes DR, Leon MB, Moses JW, et al.: Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004, 109:634-640.
47. Sousa JE, Sousa AGMR, Costa AC, et al.: Use or rapamycin-impregnated stents in coronary arteries. Transplant Proc 2003, 35(suppl 3A):165S-170S.
48. Pajari R, Hekali P, Harjola PT: Treatment of Takayasu's arteritis: an analysis of 29 patients. Thorac Cardiovasc Surg 1986, 34:176-181.
49. Teoh MK: Takayasu's arteritis with renovascular hypertension: results of surgical treatment. Cardiovasc Surg 1999, 6:626-632.
50. Tyagi S, Verma PK, Gambhir DS, et al.: Early and long-term results of subclavian angioplasty in aortoarteritis (Takayasu disease): comparison with atherosclerosis. Cardiovasc Intervent Radiol 1998, 21:219-224.
51. Sharma BK, Jain S, Bali HK, et al.: A follow-up of balloon angioplasty and de novo stenting in Takayasu arteritis. Int J Cardiol 2000, 75:S147-S152.
52. Rao SA, Mandalam KR, Rao VR, et al.: Takayasu arteritis: initial and long-term follow-up in 16 patients after percutaneous transluminal angioplasty of the descending thoracic and abdominal aorta. Radiology 1993, 189:173-179.
53. Sharma S, Gupta H, Saxena A, et al.: Results of renal angioplasty in nonspecific aortoarteritis (Takayasu disease). J Vasc Interv Radiol 1998, 9:429-435.
54. Sakaida H, Sakai N, Nagata I, et al.: Stenting for the occlusive carotid and subclavian arteries in Takayasu arteritis [in Japanese]. No Shinkei Geka 2001, 29:1033-1041.
55. Tyagi S, Kaul UA, Arora R: Endovascular stenting for unsuccessful angioplasty of the aorta in aortoarteritis. Cardiovasc Intervent Radiol 1999, 22:452-456.
56. Bali HK, Bhargava M, Jain AK, et al.: De novo stenting of descending thoracic aorta in Takayasu arteritis: intermediate-term follow-up results. J Invasive Cardiol 2000, 12:612-617.